FDA issued a Warning Letter to University Of Michigan on 9/28/2017 as a result of this inspection.
FDA investigators audited the Michigan Medicine - Ann Arbor, MI, United States facility and issued 8 inspectional observations (via FDA 483) on 29 Jun 2016.
Product details
- Category: Human Drugs
- Number of Observations: 8
- Inspection end: 29 Jun 2016
- Location: Ann Arbor, United States
- FEI: 3003531601
